{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,17]],"date-time":"2025-06-17T17:47:26Z","timestamp":1750182446883},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T00:00:00Z","timestamp":1553904000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Interv Card Electrophysiol"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1007\/s10840-019-00536-9","type":"journal-article","created":{"date-parts":[[2019,3,30]],"date-time":"2019-03-30T09:02:46Z","timestamp":1553936566000},"page":"83-91","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Predictors of rate-adaptive pacing in patients implanted with implantable cardioverter\u2013defibrillator and subsequent differential clinical outcomes"],"prefix":"10.1007","volume":"55","author":[{"given":"Nils","family":"K\u00e4llner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marin","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulrika","family":"Birgersdotter-Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kurt S.","family":"Hoffmayer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederick T.","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David E.","family":"Krummen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farshad","family":"Raissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory K.","family":"Feld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan C.","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,3,30]]},"reference":[{"issue":"7","key":"536_CR1","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1093\/europace\/eus419","volume":"15","author":"S Chen","year":"2013","unstructured":"Chen S, Ling Z, Kiuchi MG, Yin Y, Krucoff MW. The efficacy and safety of cardiac resynchronization therapy combined with implantable cardioverter defibrillator for heart failure: a meta-analysis of 5674 patients. Europace. 2013;15(7):992\u20131001. \n                    https:\/\/doi.org\/10.1093\/europace\/eus419\n                    \n                  .","journal-title":"Europace."},{"issue":"21","key":"536_CR2","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1056\/NEJMoa032423","volume":"350","author":"MR Bristow","year":"2004","unstructured":"Bristow MR, Saxon LA, Boehmer J, Krueger S, Kass DA, De Marco T, et al. Cardiac-resynchronization therapy with or without an implantable defibrillator in advanced chronic heart failure. N Engl J Med. 2004;350(21):2140\u201350. \n                    https:\/\/doi.org\/10.1056\/NEJMoa032423\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"20","key":"536_CR3","doi-asserted-by":"publisher","first-page":"2685","DOI":"10.1001\/jama.289.20.2685","volume":"289","author":"JB Young","year":"2003","unstructured":"Young JB, Abraham WT, Smith AL, Leon AR, Lieberman R, Wilkoff B, et al. Combined cardiac resynchronization and implantable cardioversion defibrillation in advanced chronic heart failure: the MIRACLE ICD trial. JAMA. 2003;289(20):2685\u201394. \n                    https:\/\/doi.org\/10.1001\/jama.289.20.2685\n                    \n                  .","journal-title":"JAMA."},{"issue":"21","key":"536_CR4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.jacc.2008.02.032","volume":"51","author":"AE Epstein","year":"2008","unstructured":"Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. ACC\/AHA\/HRS 2008 guidelines for device-based therapy of cardiac rhythm abnormalities: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC\/AHA\/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. J Am Coll Cardiol. 2008;51(21):e1\u201362. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2008.02.032\n                    \n                  .","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"536_CR5","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1056\/NEJMoa043399","volume":"352","author":"GH Bardy","year":"2005","unstructured":"Bardy GH, Lee KL, Mark DB, Poole JE, Packer DL, Boineau R, et al. Amiodarone or an implantable cardioverter-defibrillator for congestive heart failure. N Engl J Med. 2005;352(3):225\u201337. \n                    https:\/\/doi.org\/10.1056\/NEJMoa043399\n                    \n                  .","journal-title":"N Engl J Med"},{"issue":"3","key":"536_CR6","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/0167-5273(95)02316-O","volume":"49","author":"AL Clark","year":"1995","unstructured":"Clark AL, Coats AJ. Chronotropic incompetence in chronic heart failure. Int J Cardiol. 1995;49(3):225\u201331.","journal-title":"Int J Cardiol"},{"issue":"10","key":"536_CR7","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1093\/europace\/eur127","volume":"13","author":"DB Sims","year":"2011","unstructured":"Sims DB, Mignatti A, Colombo PC, Uriel N, Garcia LI, Ehlert FA, et al. Rate responsive pacing using cardiac resynchronization therapy in patients with chronotropic incompetence and chronic heart failure. Europace. 2011;13(10):1459\u201363. \n                    https:\/\/doi.org\/10.1093\/europace\/eur127\n                    \n                  .","journal-title":"Europace."},{"issue":"9","key":"536_CR8","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1111\/j.1540-8159.1999.tb00621.x","volume":"22","author":"J Lukl","year":"1999","unstructured":"Lukl J, Doupal V, Sovova E, Lubena L. Incidence and significance of chronotropic incompetence in patients with indications for primary pacemaker implantation or pacemaker replacement. Pacing Clin Electrophysiol. 1999;22(9):1284\u201391.","journal-title":"Pacing Clin Electrophysiol"},{"issue":"10","key":"536_CR9","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1111\/j.1540-8159.2005.00239.x","volume":"28","author":"C Melzer","year":"2005","unstructured":"Melzer C, Bohm M, Bondke HJ, Combs W, Baumann G, Theres H. Chronotropic incompetence in patients with an implantable cardioverter defibrillator: prevalence and predicting factors. Pacing Clin Electrophysiol. 2005;28(10):1025\u201331. \n                    https:\/\/doi.org\/10.1111\/j.1540-8159.2005.00239.x\n                    \n                  .","journal-title":"Pacing Clin Electrophysiol"},{"issue":"9","key":"536_CR10","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1161\/CIRCULATIONAHA.110.940577","volume":"123","author":"PH Brubaker","year":"2011","unstructured":"Brubaker PH, Kitzman DW. Chronotropic incompetence: causes, consequences, and management. Circulation. 2011;123(9):1010\u201320. \n                    https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.110.940577\n                    \n                  .","journal-title":"Circulation."},{"issue":"24","key":"536_CR11","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.1001\/jama.288.24.3115","volume":"288","author":"BL Wilkoff","year":"2002","unstructured":"Wilkoff BL, Cook JR, Epstein AE, Greene HL, Hallstrom AP, Hsia H, et al. Dual-chamber pacing or ventricular backup pacing in patients with an implantable defibrillator: the Dual Chamber and VVI Implantable Defibrillator (DAVID) Trial. JAMA. 2002;288(24):3115\u201323.","journal-title":"JAMA."},{"issue":"9","key":"536_CR12","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.hrthm.2008.07.015","volume":"5","author":"SC Hammill","year":"2008","unstructured":"Hammill SC, Kremers MS, Stevenson LW, Kadish AH, Heidenreich PA, Lindsay BD, et al. Review of the Registry\u2019s second year, data collected, and plans to add lead and pediatric ICD procedures. Heart Rhythm. 2008;5(9):1359\u201363. \n                    https:\/\/doi.org\/10.1016\/j.hrthm.2008.07.015\n                    \n                  .","journal-title":"Heart Rhythm"},{"key":"536_CR13","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1093\/europace\/eux274","volume":"20","author":"H Calkins","year":"2017","unstructured":"Calkins H, Hindricks G, Cappato R, Kim YH, Saad EB, Aguinaga L, et al. 2017 HRS\/EHRA\/ECAS\/APHRS\/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation. Europace. 2017;20:e1\u2013e160. \n                    https:\/\/doi.org\/10.1093\/europace\/eux274\n                    \n                  .","journal-title":"Europace."},{"issue":"10","key":"536_CR14","doi-asserted-by":"publisher","first-page":"1182","DOI":"10.1093\/europace\/eun213","volume":"10","author":"H Nagele","year":"2008","unstructured":"Nagele H, Rodiger W, Castel MA. Rate-responsive pacing in patients with heart failure: long-term results of a randomized study. Europace. 2008;10(10):1182\u20138. \n                    https:\/\/doi.org\/10.1093\/europace\/eun213\n                    \n                  .","journal-title":"Europace."},{"issue":"6","key":"536_CR15","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1111\/pace.12856","volume":"39","author":"A Fontenla","year":"2016","unstructured":"Fontenla A, Salguero R, Martinez-Ferrer JB, Rodriguez A, Alzueta J, Garcia E, et al. Atrial rate-responsive pacing and incidence of sustained atrial arrhythmias in patients with implantable cardioverter defibrillators. Pacing Clin Electrophysiol. 2016;39(6):548\u201356. \n                    https:\/\/doi.org\/10.1111\/pace.12856\n                    \n                  .","journal-title":"Pacing Clin Electrophysiol"},{"issue":"4","key":"536_CR16","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1093\/europace\/eup433","volume":"12","author":"T Kawasaki","year":"2010","unstructured":"Kawasaki T, Kaimoto S, Sakatani T, Miki S, Kamitani T, Kuribayashi T, et al. Chronotropic incompetence and autonomic dysfunction in patients without structural heart disease. Europace. 2010;12(4):561\u20136. \n                    https:\/\/doi.org\/10.1093\/europace\/eup433\n                    \n                  .","journal-title":"Europace."},{"issue":"12","key":"536_CR17","doi-asserted-by":"publisher","first-page":"2292","DOI":"10.1016\/j.jacc.2005.02.097","volume":"46","author":"HF Tse","year":"2005","unstructured":"Tse HF, Siu CW, Lee KL, Fan K, Chan HW, Tang MO, et al. The incremental benefit of rate-adaptive pacing on exercise performance during cardiac resynchronization therapy. J Am Coll Cardiol. 2005;46(12):2292\u20137. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2005.02.097\n                    \n                  .","journal-title":"J Am Coll Cardiol"},{"key":"536_CR18","doi-asserted-by":"publisher","first-page":"17D","DOI":"10.1016\/S0002-9149(98)01038-8","volume":"83","author":"E Alt","year":"1999","unstructured":"Alt E. What is the ideal rate-adaptive sensor for patients with implantable cardioverter defibrillators: lessons from cardiac pacing. Am J Cardiol. 1999;83:17D\u201323D.","journal-title":"Am J Cardiol"},{"key":"536_CR19","doi-asserted-by":"publisher","unstructured":"Olshansky B, Richards M, Sharma A, Wold N, Jones P, Perschbacher D, et al. Survival after rate-responsive programming in patients with cardiac resynchronization therapy-defibrillator implants is associated with a novel parameter: the heart rate score. Circ Arrhythm Electrophysiol. 2016;9(8). \n                    https:\/\/doi.org\/10.1161\/CIRCEP.115.003806\n                    \n                  .","DOI":"10.1161\/CIRCEP.115.003806"},{"issue":"13","key":"536_CR20","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1161\/01.CIR.0000118464.48959.1C","volume":"109","author":"P Mulder","year":"2004","unstructured":"Mulder P, Barbier S, Chagraoui A, Richard V, Henry JP, Lallemand F, et al. Long-term heart rate reduction induced by the selective I(f) current inhibitor ivabradine improves left ventricular function and intrinsic myocardial structure in congestive heart failure. Circulation. 2004;109(13):1674\u20139. \n                    https:\/\/doi.org\/10.1161\/01.CIR.0000118464.48959.1C\n                    \n                  .","journal-title":"Circulation."},{"issue":"9","key":"536_CR21","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1016\/j.jacc.2007.04.079","volume":"50","author":"K Fox","year":"2007","unstructured":"Fox K, Borer JS, Camm AJ, Danchin N, Ferrari R, Lopez Sendon JL, et al. Resting heart rate in cardiovascular disease. J Am Coll Cardiol. 2007;50(9):823\u201330. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2007.04.079\n                    \n                  .","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"536_CR22","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1111\/j.1540-8167.2008.01422.x","volume":"20","author":"AH Maass","year":"2009","unstructured":"Maass AH, Buck S, Nieuwland W, Brugemann J, van Veldhuisen DJ, Van Gelder IC. Importance of heart rate during exercise for response to cardiac resynchronization therapy. J Cardiovasc Electrophysiol. 2009;20(7):773\u201380. \n                    https:\/\/doi.org\/10.1111\/j.1540-8167.2008.01422.x\n                    \n                  .","journal-title":"J Cardiovasc Electrophysiol"}],"container-title":["Journal of Interventional Cardiac Electrophysiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-019-00536-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10840-019-00536-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10840-019-00536-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,29]],"date-time":"2020-03-29T00:17:18Z","timestamp":1585441038000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10840-019-00536-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,30]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["536"],"URL":"https:\/\/doi.org\/10.1007\/s10840-019-00536-9","relation":{},"ISSN":["1383-875X","1572-8595"],"issn-type":[{"value":"1383-875X","type":"print"},{"value":"1572-8595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,30]]},"assertion":[{"value":"21 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 March 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Ethical approval for this study was granted by the UCSD Institutional Review Board.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The UCSD Cardiac Electrophysiology Fellowship Training Program receives support from Medtronic, Inc., St. Jude Medical, Inc., Biotronik, Inc., Boston-Scientific, Inc., and Biosense-Webster, Inc.Dr. Jonathan C. Hsu reports receiving honoraria from Medtronic, St. Jude Medical, Boston Scientific and Biotronik and research grants from Biosense-Webster and Biotronik.Dr. Gregory K. Feld, Director CCEP Fellowship Training program, receives fellowship stipend support from Biotronik, Inc., Medtronic, Inc., St. Jude Medical, Inc., Boston Scientific, Inc., and Biosense Webster, Inc.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The UCSD Human Research Protection Program approved analysis of the data from our institution for this study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Owing to the retrospective and observational nature of this study, written informed consent was waived.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}